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Abstract
Background: Advancing age progressively impacts on risk and severity of chronic disease. It also modifies the
epigenome, with changes in DNA methylation, due to both random drift and variation within specific functional
loci.
Results: In a discovery set of 2238 peripheral-blood genome-wide DNA methylomes aged 19–82 years, we identify
71 age-associated differentially methylated regions within the linkage disequilibrium blocks of the single nucleotide
polymorphisms from the NIH genome-wide association study catalogue. This included 52 novel regions, 29 within
loci not covered by 450 k or 27 k Illumina array, and with enrichment for DNase-I Hypersensitivity sites across the
full range of tissues. These age-associated differentially methylated regions also show marked enrichment for
enhancers and poised promoters across multiple cell types. In a replication set of 2084 DNA methylomes, 95.7 % of
the age-associated differentially methylated regions showed the same direction of ageing effect, with 80.3 % and
53.5 % replicated to p < 0.05 and p < 1.85 × 10–8, respectively.
Conclusion: By analysing the functionally enriched disease and trait-associated regions of the human genome, we
identify novel epigenetic ageing changes, which could be useful biomarkers or provide mechanistic insights into
age-related common diseases.
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Background
Age is a risk factor for multiple chronic diseases. It im-
pacts on all organ systems leading to decreased func-
tionality and eventual death [1]. Epigenetic changes
associated with the ageing process, specifically DNA
methylation, have been identified in a number of studies
[2–16]. While stochastic epigenetic drift does occur [17],
non-random changes are seen within specific functional
loci, such as increased DNA methylation in the pro-
moters of the target genes of polycomb group proteins
[3] and bivalent chromatin regions or poised promoters
[4]. Additionally, recent formulation of an epigenetic
‘clock’ [9] has led to the observation that accelerated dis-
cordance between the DNA methylation estimate and
actual chronological age is a risk factor for all-cause
mortality in later life [18].
The ageing-associated DNA methylation signatures
identified to date have almost exclusively been via targeted
array based methodology (Illumina 27 k or 450 k). Notable
exceptions are a study by McClay et al. performed via me-
thyl binding domain enriched second-generation sequen-
cing (MBD-seq) [12] and Heyn et al. comparing a single
centenarian with a single newborn with whole genome
bisulphite sequencing (WGBS) data [6]. Within heteroge-
neous peripheral blood, an increase in the myeloid frac-
tion of blood cell sub-types is known to occur with
advancing age [19] and must be accounted for in these
analyses. DNA methylation changes in peripheral blood
may therefore represent this myeloid skewing, biological
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cascades leading to upregulation or downregulation of
specialised cell subtypes [20], or additional undefined ac-
tive or passive changes associated with age [21].
We analysed 2238 unique DNA methylomes for
changes associated with chronological age. These data
were generated by genome-wide methylated DNA im-
munoprecipitation Illumina second-generation sequen-
cing (MeDIP-seq) in peripheral blood. MeDIP-seq
methylome results identify broader regional changes
compared with targeted individual CpG array ap-
proaches and are not limited to the array-predefined cy-
tosines. Data were included on significant influencing
variables including full blood count, smoking status and
batch. To account for the strong genetic effects inherent
with DNA methylation analysis, especially by techniques
such as MeDIP-seq [22] we incorporated common SNP
genotyping data available on all these individuals.
We focused on the a priori functional regions [23], the
linkage disequilibrium (LD) blocks of all of the phenotype
and disease-related single-nucleotide polymorphisms
(SNPs) entered in the genome-wide association study
(GWAS) catalogue [24] (8093 curated GWAS SNPs with p
value < 1 × 10–7 residing within 2709 distinct LD blocks,
~22.1 % of the genome). Multiple strands of evidence have
now accrued from the ENCODE consortium and other
regulatory datasets that the regions identified through the
thousands of GWAS studies performed to date are
enriched for active loci [25, 26]. We pursued this strategy
to explore the GWAS LD blocks in order to identify novel
epigenetic changes that were more likely to be functional
and, due to their co-location, would enable direct integra-
tion into future locus-specific common disease investiga-
tions. As age impacts on the penetrance and severity of
many of these common diseases and phenotypes, this ana-
lysis enabled us to specifically explore these blocks for age-
related changes. This is particularly of interest because
changes identified in studies, such as the DNA methylation
‘clock’ and others, can be seen across multiple tissues [9,
15]. Thus these blood-based findings could, in some cases,
have impact not just in haematological or immunological
disorders, but also within the most disease-relevant tissue.
The epigenetic state within a locus can be obligatory
or fixed due to the underlying genetic framework or may
vary, facilitated by particular sequence constructs [27].
Using haplotype-tagging common SNP data in these in-
dividuals, we could control for the obligatory genetic ef-
fects in the LD blocks. We could also subsequently
investigate whether facilitative DNA methylation ageing
changes differed with respect to common risk versus
non-risk haplotype background within these GWAS re-
gions. The potential of genetically facilitated ageing
modifications has been explored [10, 16] and its direct
assessment could add additional mechanistic insight
within these disease-associated loci.
Results
GWAS LD block regions are functionally enriched
Multiple studies have indicated that the regions identi-
fied by GWAS are functionally enriched [25, 26]. To fur-
ther demonstrate this, we explored public ENCODE
data and compared the 2709 distinct GWAS LD blocks
(~22.1 % of the genome) to the remainder of the gen-
ome. We focused on the DNase I Hypersensitivity site
(DHS) due to their broad capacity to act as functional
indicators [28]. We also explored the recently identified
DNA methylation-sensitive transcription factor NRF1
[29]. We found that DHSs and NRF1 both show signifi-
cant occupancy enrichment within this portion of the
genome (both Fisher’s exact test p < 2.2 × 10–16, odds
ratio (OR) = 1.70 and 2.26, confidence intervals (CI)
1.69–1.71 and 2.17–2.35, respectively).
Age-associated differentially methylated regions
From our discovery sample set of 2238 MeDIP-seq DNA
methylomes, we identified 115 individual 500-bp win-
dows that passed a Bonferroni corrected significance
level (p < 1.85 × 10–8, Fig. 1; bidirectional Manhattan
plot) within these GWAS LD block regions. Due to over-
lapping and adjacent windows, these merged into 71
discrete age-associated differentially methylated regions
(a-DMRs) (Additional file 1). The a-DMRs were 54.9 %
and 45.1 % hypermethylated and hypomethylated with
increasing age, respectively. They were on average the
size of ~0.65 kb and include 1546 individual CpGs.
To ascertain the novelty of our results, we compared
the 71 a-DMRs with results from 14 prior studies also
performed in blood [3–16]. All these studies were array-
based and therefore focused on a defined set of CpGs,
except for McClay et al. (MBD-seq) [12] and Heyn et al.
(WGBS) [6]. The array-based studies are less in sample
size, except for a meta-analysis [9], with a maximum of
around 1000 individuals, but the majority is much
smaller. In total, 52 (73.2 %) of our a-DMRs were previ-
ously unidentified associations with age (Additional file
2: Table S1). Highlighting the use of the MeDIP-seq
data, 29 of the a-DMR regions identified (40.8 %) were
not covered at all by any CpG probe from either the
27 k or 450 k array platforms. A further 11 a-DMRs are
covered on these arrays by only one or two CpGs.
a-DMR chromatin segmentation is enriched for poised
promoters and enhancers
To identify chromatin-defined epigenomic functional
enrichments, the a-DMRs were compared with both
ChromHMM [30] and the Combined (ChromHMM and
Segway [31]) genome segmentation analysis from nine
and six tissue types, respectively (Fig. 2a and b). This
was in a comparison with the GWAS LD blocks (using
500-bp non-overlapping windows), not the entire
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Fig. 1 Bidirectional Manhattan plot of age-associated differentially methylated regions (a-DMRs). Loci with a positive correlated with age are
displayed in the positive y-axis and those regions where DNA methylation changes negatively correlate with age are displayed in the negative y-axis
Fig. 2 Chromatin segmentation enrichment. a Overlap with a-DMRs and GWAS LD blocks for ENCODE ChromHMM [30] genome segmentation from
ENCODE in nine tissues (data via and graph adapted from Epiexplorer [85]). Strong poised promoter enrichment seen. Observed versus expected for
the GWAS LD block regions. b Overlap with a-DMRs and LD blocks for combined genome segmentation from ENCODE (ChromHMM [30] and Segway
[31]) in six tissues. Strong enrichment for enhancers is evident. Sphere size is proportional to genomic space. TSS predicted promoter region including
transcription start site, PF predicted promoter flanking region, E predicted enhancer, WE predicted weak enhancer or open chromatin cis regulatory
element, CTCF CTCF enriched element, T predicted transcribed region, R predicted repressed or low activity region
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genome, as these regions already have an inherent func-
tional increase [23]. Ageing changes have previously been
identified in poised promoters [4] and in this ChromHMM
analysis, this enrichment was particularly strong (Fig. 2a,
~45 % cf. ~3 % within LD blocks, χ2p < 2.2 × 10−16). Strong
and weak promoters are also more prevalent, but interest-
ingly, there is a separation between the delineated
ChromHMM enhancer classes. Enhancer states 4 and 6
show increases, however 5 and 7 do not. The major con-
stituent difference between these classes is higher levels of
H3K4me2 (state 4: 99 % and state 6: 75 % versus state 5:
57 % and state 7: 3 %) and recent data from Wang et al.
indicate that specifically high levels of H3K4me2 reliably
identify transcription factor binding regions across different
cells [32].
As stated we also compared the a-DMRs with the
combined segmentation that incorporates overlap with
the Segway algorithm and results in more discrete, re-
duced and potentially more accurate categories [31]
(Fig. 2b). This classification does not include the poised
promoter subcategory. It classifies an extremely strong
enrichment in enhancer sequence across these multiple
cell types (52.1 % a-DMRs versus 9.46 % in LD block
non overlapping 500-bp windows, χ2p < 2.2 × 10−16).
a-DMRs are enriched for genetic functional indicators
We then examined additional specified genetic and func-
tional regions, in the same manner as the segmentation
analysis above, by again comparison with the regions
within the GWAS LD blocks, not the entire genome. This
revealed greater fold enrichment for a-DMRs within CpG
Islands (CGI) themselves (14.33-fold), even stronger, in
fact, than for CpG Island shores (7.22-fold; Fig. 3). Thus
a-DMRs differ from the findings in tissue-specific [33],
reprogramming-specific [34] and species-specific [35]
DMRs which are more prevalent in CGI shores. a-DMRs
also showed enrichment within functional indicators such
as DNase I hypersensitivity sites and transcription factor
ChIP-seq binding sites, as well as even stronger fold
enrichments for CTCF and Sp1 ENCODE ChIP-seq data
across all tissues (χ2p all < 1 × 10–10). The eRNA expres-
sion validated FANTOM5 enhancer set [36] also showed
a strong increase for a-DMR locations (χ2p = 2.2 × 10–16).
Repeat classes in total were significantly depleted by com-
parison (χ2p = 6.70 × 10–9), although potential mapping is-
sues to these regions may confound this.
a-DMR Gene Ontology analysis
Gene Ontology enrichment was performed with the
Genomic Regions Enrichment of Annotations Tool
(GREAT) comparing the a-DMRs to the region
contained within the LD blocks as the background set
(Additional file 2: Table S2). This revealed an increase
for categories (all Bonferroni p < 0.05), such as Molecular
classifications of DNA binding; Nucleic acid binding tran-
scription factor activity; Sequence-specific DNA binding
transcription factor activity; and Nucleic acid binding. An
enrichment in the PRD Gene family was also identified
which includes multiple homeobox genes.
Hypermethylated and hypomethylated a-DMR transcription
factor binding site analysis
We then examined the sequence within the 38 hyper-
methylated and 33 hypomethylated a-DMRs separately
and explored for sequence enrichment of specific tran-
scription factor binding sites (TFBSs) with both the tran-
scription factor affinity prediction (TRAP) [37] and
MEME-ChIP algorithms. [38] TRAP identified four
TFBSs, three within hypomethylated DMRs including
NFE2L2 (p < 0.05, Benjamini–Hochberg corrected;
Table 1), previously associated with age-related diseases
[39]. The MEME analysis, which identifies sequences
agnostically, before then comparing them to known mo-
tifs in TOMTOM, found three sequences in hypomethy-
lated a-DMRs, that were found to closely match a
number of motifs and only one match for
Fig. 3 Fold enrichments for a-DMRs compared to LD block non-
overlapped 500-bp windows. All categories are enriched in a-DMRs
(χ2p all < 1 × 10–5) except for transcripts (near identical fraction), SINE
and LTR repeats (non-significant) and all repeats and LINE repeats,
which are significantly depleted (χ2p = 6.73 × 10–9 and 2.81 × 10–3,
respectively). CGI CpG Islands, TSS transcription start sites, DNase I
HSs DNase I hypersensitivity sites in 125 cell types, TFBS transcription
factor binding sites, CTCF and Sp1 from all tissues (ENCODE v3),
Repeats All, SINE, LINE, LTR repeats, FANTOM5 Enhancers [36], Dynamic
Regions [66] and Conserved (100 Vertebrate) regions [87]
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hypermethylated a-DMRs (Table 2). These results in-
cluded the SP1 motif, that is of interest as it corresponds
with the ENCODE TF CHIP-seq enrichment data and
also due to the known methylation-determining region
effect of this TFBS [40] (Fig. 4). An enrichment for the
binding motif of KLF14 is noteworthy due this gene’s
known role as a master trans-regulator in metabolism
[41].
No enrichment with blood-cell derived DNA methylome
changes
The myeloid skew with age is an acknowledged con-
founding factor in the analysis of ageing changes. How-
ever, Yuan et al. have presented data that the majority of
age-related drift is independent of increase of granulo-
cytes in comparison to lymphocytes [42].
We had included available leukocyte fraction data in our
linear mixed-effect model, but to further test whether we
had accounted for these effects we performed additional
investigations. We first compared our a-DMRs with the
500 leukocyte subtype-related differentially methylated
CpG positions (L-DMPs) identified by Houseman et al.
[43]. None of the a-DMRs overlap with these L-DMPs.
Next, to check for blood-cell type bias we performed six
epigenome-wide association studies (EWAS) in 54 mono-
zygotic (MZ) discordant twins with precise white blood
cell data for CD4+ helper T; CD8+ cytotoxic T; T cell; nat-
ural killer cell; CD34+ multipotential haematopoietic stem
cell; and B cells [44] within the entire DNA methylome
dataset. In this MZ analysis, 6.44 % of all windows
have p < 0.05 for any of these six blood traits. However, a
slightly lesser value of 6.38 % have a p < 0.05, and none
near Bonferroni, within the a-DMR windows. Therefore,
there is no strong evidence for enrichment for blood-cell
changes in the a-DMRs (χ2p > 0.05).
Validation of a-DMRs
In a dataset of 811 individuals that possessed 450 k array
blood data (mean age, 58.0 years; age range, 18.6–81.7 years;
88.9 % overlap with MeDIP samples), we attempted to val-
idate the fraction of a-DMRs that had overlapping probe(s).
Thirty-eight a-DMRs possess at least one overlapping
450 k probe and, of these, 36 a-DMRs included probe(s)
that passed quality control (QC). We performed a similar
linear mixed effect model analysis for ageing methylation
changes including the same covariant information as in our
MEDIP-seq data. In this investigation, 32 (88.9 %) and 25
(69.4 %) of these 36 a-DMRs had at least one CpG with a
nominal or Bonferroni significant (p < 1 × 10–7) results with
the same directional change, respectively (Additional file 2:
Table S3). This thus strongly supports our results but also
shows the unique power of our analysis.
Of note, those a-DMRs that did possess an overlapping
probe(s) were almost exclusively those where methylation
increases with age, 34 of the total 38 and 31 of the 32 with
at least nominally significant probes. This is thus consist-
ent with early array studies that predominately found this
direction of change, but also starkly revealing the bias of
the CpGs present on the array.
Table 1 TRAP transcription factor motif prediction
Rank Combined
p value
Corrected p value
(Benjamini–Hochberg)
Matrix ID Motif a-DMR
1 3.84 × 10–6 4.53 × 10–4 MA0150.1 NFE2L2 Hypo
2 1.52 × 10–5 8.97 × 10–4 MA0041.1 FOXI1 Hypo
3 4.13 × 10–5 1.63 × 10–3 MA0041.1 FOXD3 Hypo
1 1.99 × 10–5 2.35 × 10–3 MA0152.1 NFATC2 Hyper
Enrichment for defined TFBS within hypomethylated and hypermethylated
a-DMRs via the TRAP algorithm [37]
Table 2 MEME/TOMTOM agnostic motif analysis
Hypomethylated motif 1 SPDEF_DBD_3
Hypomethylated motif 2 FOXC1_DBD_1
ONECUT3_DBD
UP00037_1 (Zfp105_primary)
UP00097_2 (Mtf1_secondary)
ONECUT1_DBD
Hypomethylated motif 3 SP8_DBD
SP1_DBD
SP3_DBD
KLF14_DBD
Klf12_DBD
KLF16_DBD
SP4_full
UP00011_2 (Irf6_secondary).
Hypermethylated motif 1 SPDEF_DBD_3
Enrichment for defined TFBS within hypomethylated and hypermethylated
a-DMRs via MEME/TOMTOM motif analysis [38]
Fig. 4 MEME-ChIP [38] enriched sequence identified in hypomethylated
a-DMRs (below) and TOMTOM (v4.10.2) enrichment for the SP1
transcription factor motif (above)
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Replication of a-DMRs
The significant windows of the 71 a-DMR loci were
assessed in a non-overlapping dataset of 2084 DNA
methylomes also sourced from TwinsUK. This analysis
was performed identically as for the discovery set, but
with reduced covariate information for the genotype,
smoking or leukocyte categories. Of the total number of
115 Bonferroni significant ageing-related windows,
96.5 % (111) show the same direction of effect, 84.3 %
(97) nominal significance (p < 0.05) and 60.9 % (70) are
even significant beyond the discovery Bonferroni level
(p < 1.85 × 10–8). Of the merged 71 a-DMRs, 68 (95.7 %)
have consistent windows with the same direction of ef-
fect, 57 (80.3 %) include a window that is nominally sig-
nificant (p < 0.05) and in 38 (53.5 %), this reaches
Bonferroni significance in this replication dataset (p <
1.85 × 10–8; Additional file 2: Table S1).
Individual a-DMR loci
We identified numerous a-DMRs in genetic regions with
intriguing additional evidence from the literature for po-
tential roles in age-related phenotypes. A selection of
these a-DMR results are discussed below and are shown
in Fig. 5, Additional file 3: Figure S1, and all in Additional
file 4: Figure S2. The top a-DMR overlapped an intragenic
3′ CpG island and shore region within the HSPA2
(Heat Shock 70 kDa Protein 2) gene (chr14:65,008,750-
65,009,500), with the peak window p = 7.14 × 10–21. It
is within a GM12878 ChromHMM predicted poised
promoter and possesses strong vertebrate conservation
(Fig. 5a). This precise locus was also previously identi-
fied in the MBD-seq study by McClay et al. [12] and
also in a paediatric cohort via the 27 k array [5].
A number of physiologically interesting genetic loci
are associated with the a-DMRs. This includes novel
DNA hypomethylation in the IGFBP4 promoter, with
previously identified ageing-related increases in this gene
product in both human serum and bone and a proposed
role in bone loss in the elderly [45] (Fig. 5b). Another
novel finding was within an intragenic a-DMR within
CDC14B, residing over multiple-tissue enhancer predic-
tions (Additional file 3: Figure S1c). A Cdc14b knockout
mouse model displays an early ageing phenotype and a
defective DNA damage response [46]. Murine data also
shows enhancer evidence in this location and conserved
epigenomic enhancer signals have been shown to be
highly informative in disease models [47].
An intragenic a-DMR within HFE, the Haemachroma-
tosis gene, resides upstream of the two common non-
synonymous SNPs causative in this autosomal recessive
condition (Additional file 3: Figure S1d). This is a low
penetrance age-related phenotype with the symptoms
only usually appearing between 30 and 50 years. The a-
DMR overlaps predicted weak enhancer signal in
hepatocellular-derived HepG2 ChromHMM data. If this
novel change is occurring across additional tissues, such
Fig. 5 Selected a-DMRs within (i) genomic location; from top: a-DMRs (purple), gene, DNase I HS clusters, transcription factor ChIP-seq,
ChromHMM segmentation, combined segmentation and conservation; and (ii) scatterplot: x-axis = age, y-axis = normalised methylation. a) HPAS2
b) IGFBP4
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as the liver, it may be involved in the pathophysiology.
However, there is no current array coverage with the
nearest probe > ~1 kb further upstream away. Located in
the gene body within the 0.3–8 kb downstream region of
the promoter, it would also be defined as an undefined
intragenic DMR (uiDMR), as per Schultz et al., shown to
strongly influence expression [48].
Two a-DMRs reside within the vicinity of the NR4A2
gene, one within an intragenic CpG Island shore and the
other ~1.5 kb downstream from this gene, both overlap-
ping predicted poised promoters (Additional file 3: Fig-
ure S1e). This gene itself is associated with nutritional
status, postnatal development and hormonal imbalances
[49]. Another a-DMR resides in the poised promoter of
the growth hormone secretoagogue receptor (GHSR), or
Ghrelin receptor, for the orexigenic hormone ghrelin
that is active in the hypothalamus (Additional file 3: Fig-
ure S1f ) with potential age-related effects [50]. Add-
itional novel a-DMRs in genes of interest include BMI1,
with an associated brain ageing phenotype in mouse
knockout [51], and C14orf39, with a non-synonymous
SNP associated with menarche [52].
Earlier studies have found numerous ageing changes
within cancer-related genes and we also find many genes
in this category, including previously identified loci in
CDKN2A (also with a well-known role in ageing [53]),
MGA and ZNF577, and novel changes in ZNF300P1
(Additional file 3: Figure S1g), STEAP1, FOXE1 and
PAX1. Four overlapping significant windows comprise
the 1.25 kb a-DMR in ZNF577 that completely overlaps
its 5′ promoter CpG island (Additional file 3: Figure
S1h). This CpG island is known to be hypermethylated
in lung and other cancers, but of particular interest to
this blood tissue study, it was also found to be the only
gene with promoter hypermethylation in a study of poly-
cythaemia vera (PCV) JAK2 V617F mutation individuals
[54]. PCV is usually a late onset disease that is com-
monly diagnosed around 60–65 years. Subclinical PCV
with undetectable low-level JAK2 somatic clonal muta-
tions could potentially contribute to this signature
within this ageing cohort. This a-DMR location also
overlaps with three previous studies [6, 8, 11].
All the above-mentioned genes were significant be-
yond the Bonferroni level in the replication set, except
for C14orf39 (replication p = 2.953 × 10–6).
Multi-tissue regulatory enrichment
We investigated the a-DMRs to ascertain whether they
were more likely to fall within DHSs identified within
blood-cell tissues and/or other cell types. This revealed
that while the a-DMRs are enriched within this regula-
tory marker in blood cells, they were in fact significant
across all tissue types and not particularly within haem-
atological tissue (125 ENCODE DHS tissue types [55],
all χ2p < 2.2 × 10−16; Fig. 6). This implies their systemic
functional potential. Those that do reside within blood
are an interesting subset due to their direct mechanistic
interpretation. Twelve a-DMRs show a strong enrichment
in blood-related DHS (≥50 % of the 22 blood-cell related
analyses out of 125 total, Additional file 2: Table S4).
These include novel a-DMRs within the promoter of
TAOK2 involved in the MAPK signalling pathway impli-
cated in degenerative disease [56] (Additional file 3: Figure
S1i) and within the promoter of an isoform of FADS2 as-
sociated with liver omega desaturation [57]. a-DMRs that
overlapped with previous studies include: an intragenic re-
gion within AFF1, the 3′ portion of the oncogenic fusion
gene causative in acute lymphoblastic leukaemia [58]
(Additional file 3: Figure S1j); the promoter CpG Island
shore region of the transcription factor KLF9 induced by
oxidative stress [59]; and the ZNF577 a-DMR mentioned
above with respect to PCV.
a-DMRs that reside within blood-related disease regions
Age-related DNA methylation changes within GWAS
disease-associated regions where blood tissue may be
directly involved in the pathophysiology make strong
candidates for an epigenetic ageing and genetic inter-
action. The 71 a-DMRs reside within 64 GWAS LD
blocks, containing 242 unique SNPs that have been re-
lated to 534 overlapping diseases and traits (Additional
file 2: Table S5). When categorised by 15 broad disease
classes [60], we found associations for haematological
measures (24 associations), autoimmune-related diseases
(34) and large numbers of associations across an over-
lapping range of serum metabolites (257). All of these
may influence or could be represented in blood physio-
logical changes (Additional file 2: Table S6). In fact, a
large proportion of the a-DMRs (33, ~46.48 %) are im-
plicated in these three broad disease categories. Add-
itionally, within the cancer category, there are two
blood-related malignancies with a-DMRs within their
GWAS association risk loci: multiple myeloma and acute
lymphoblastic leukaemia.
Age-related disease enrichment
We additionally parsed our a-DMR results for an enrich-
ment for ageing-related diseases. While many disorders
and phenotypes have some complex age component, we
restricted this analysis to adult-onset cancers, age-
related and degenerative neurological, musculoskeletal,
metabolic, cardiac and cerebrovascular diseases, as well
as cognitive decline and age-of-onset analyses (Additional
file 2: Table S7). This revealed an enrichment for the a-
DMRs to reside within GWAS LD blocks for an age-
related phenotype. These disorders are found in 26.7 % of
the GWAS LD blocks, compared to 39.4 % of the a-DMR
co-locating GWAS LD blocks, Fisher’s exact test p = 0.02,
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OR= 1.81, CI 1.08–3.02). Permutation analysis, by ran-
domly selecting 1000 times the age-related fraction of
GWAS LD blocks from the total set and then testing over-
lap with the observed a-DMRs, significantly supported
this enrichment (empirical p value = 0.021).
Interaction with genotype
While genetic effects can strongly confound an EWAS
analysis, we attempted to explore our dataset for any
evidence of a genetic facilitated effect, through common
haplotype differences, on DNA methylation changes oc-
curring with age. We performed an interactive analysis
between the LD block haplotype tagging genotype and
age with DNA methylation. We then overlapped these
results with the a-DMR regions, where we had excluded
genotype being the sole driver of the signal. Thus we are
not looking for obligatory differences, but instead an ac-
centuated facilitated ageing signature on either the risk
or non-risk haplotype, with the potential to then have
influence on the associated phenotype or disease.
Three a-DMRs were identified that co-located with
significant interaction results (all p < 0.05, Additional file
5: Figure S3A–C). One of these included the enhancer
located a-DMR in the TRAK1 locus associated with the
late onset neoplasm, multiple myeloma (rs1052501).
Other SNPs within this LD block associate with add-
itional phenotypes, such as blood pressure. The G risk
allele carriers did not show the same increase in DNA
methylation with age, possibly indicating that these indi-
viduals have a prematurely higher DNA methylation in
this locus and therefore the age-related trend is not seen.
The a-DMR within the promoter of the MGA promoter
Fig. 6 DHS fold enrichments for a-DMRs compared to the regions within LD blocks. y-axis indicates log2 fold enrichment. An enrichment across
multiple tissue types is seen
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also shows this trend, with the SNP rs28374715 in this
LD block associated with ulcerative colitis. The a-DMR
within the promoter of the IGFBP4 gene, previously
mentioned with regards to age-related bone loss, shows
methylation change in those individuals with the SNP
rs584438 T allele, which is related to height, decreasing
more strongly than the non-associated haplotype.
Discussion
Epigenomic changes with advancing years provide a
novel avenue to explore the physiology and mechanisms
of ageing [9]. This is clear with the observed discordance
between chronological and predicted epigenetic age and
its association with mortality [18]. The driving role of
heterochromatic epigenetic changes in ageing has also
been displayed in the human premature ageing disorder
Werner syndrome [61]. In this study, we performed the
largest analysis of DNA methylation changes with age to
date and identified novel age-related regions that show
strong functional enrichment over a range of publicly
available evidence. In comparison to previous array
findings, in almost half of these loci DNA methyla-
tion decreased with age. Those a-DMRs that did
overlap array probes were almost exclusively regions
that hypermethylate with age, clearly displaying the
bias of the array to CpGs possessing this directional
change only. The identification of these novel ageing
changes in loci with no array coverage reinforces the
insights more genome-wide methodology can pro-
vide. Furthermore, additional evidence that strong
associations are identified in this study comes from
the convincing replication in an independent large
dataset.
The a-DMR loci co-locate with many physiologically
interesting genes, including novel and robustly replicated
findings in IGFBP4, CDC14B, HFE, BMI1 and TAOK2,
among others. These loci reside within regions that have
strong genetic associations with common diseases and
therefore are novel candidates for potential genetic and
epigenetic interactions, particularly for late-onset condi-
tions. Blood-derived DNA methylation ageing changes
can be concordant across a range of other tissues [9, 15],
consequently some of these alterations may act in the
most disease-relevant tissue. We identified that our age-
ing changes were enriched for the regulatory regions of
multiple tissue types. Furthermore, epigenetic variation
is strongly intertwined with sequence-specific transcrip-
tion factor interaction and binding [62, 63] and thus
these changes can be a key to unlocking the precise mo-
lecular mechanisms involved.
Multiple cell-types are present in peripheral blood,
therefore its analysis represents a meta-epigenome [64],
so that changes in subpopulation proportions will be de-
tected as epigenetic variation. However, we found no
strong evidence of enrichment for blood cell-type related
DNA methylation changes within these a-DMRs. Add-
itionally, contribution to DNA methylome variation by
subclinical or unknown pathology, as identified in recent
age-related brain analysis via neuropathologies [65], can-
not be completely excluded. Although this is unlikely to
be present in our samples, since TwinsUK participants
are recruited as predominately healthy volunteers, unse-
lected for any diseases.
There are inherent power benefits from this study that
is six-fold larger in sample size to the only comparable
previous analysis for regional changes by McClay et al.
[12]. Robust DMRs are strongly enriched for function
[66]; however, denser coverage is required for successful
DMR calling than is provided by 450 k array [67]. Fun-
damentally, arrays are designed to identify individual
CpGs in contrast to regional approaches, such as
MeDIP-seq and MBD-seq, which can only identify con-
sistent regional variation. Thus while the 71 a-DMRs
may not initially compare to multiple a-DMPs identified
with arrays, this is inherent with these methodical differ-
ences. Our results are directly analogous to the 11 a-
DMRs identified in the other large-scale genome-wide
approach of McClay et al. [12].
The finding in this study of aberrant DNA methylation
within disease-related loci proposes potential interrela-
tionships with ageing changes and disease susceptibility or
downstream consequence. Evidence that age-associated
DNA methylation may predispose to cancer by reducing
threshold of malignant transformation has been previously
shown [68] and is implicated in the increased cancer
incidence with age [15]. The ability of epimutations to
pathogenically drive disease in the same fashion as
genetic mutation, such as in acute myeloid leukaemia
[69], further support the pathological potential of these
changes and also the possibilities in regards to non-
malignant disease [70].
Conclusion
The loci we have investigated are associated with human
traits and disease through robust and replicated GWAS.
Thus these epigenetic changes with age will be valuable
measures to incorporate in these disease models. With the
availability of genotype data, we have also been able to test
and identify variation in this signal between risk and non-
risk haplotypes. With a more detailed understanding of
the haplotypic nature of both genetic risk [71, 72], but also
epigenetic risk, through the integration of obligatory and
facilitated epigenetic changes [27, 73, 74], a more precise
understanding of common disease will emerge. This well-
defined allele-specific genetic and epigenetic variability
should accelerate mechanistic discoveries into ageing’s
role in late-onset disorders and the biology of human age-
ing and disease.
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Methods
Participants
Participants are from the deeply phenotyped UK
Adult Twin Register (TwinsUK Resource) [75] based
at St Thomas’ Hospital, London. Phenotyping occurs
at interview when blood is also taken for haemato-
logical analysis and DNA extraction. Storage is in
EDTA tubes at –80 °C. Nucleon Genomic DNA
Extraction Kits are used for DNA extraction which
are then stored at –20 °C in TE buffer. Haematological
analysis for full blood count was performed on the major-
ity of extracted bloods. Smoking status is recorded at this
time or within the nearest five years via questionnaire if
not available. Zygosity is determined by twinning ques-
tionnaire and confirmed by genotyping.
The discovery set consisted of 2238 DNA methylomes,
which were all female, therefore sex-specific modifica-
tions were removed [76], and included longitudinal data
with two or more time points on 408 individuals (mean
time difference 2.18 years) and single time point data on
1350. These 1758 individuals included 203 MZ twin
pairs and 489 MZ singletons and 371 dizygotic (DZ)
pairs and 121 DZ singletons, therefore comprising equal
numbers of MZ (50.9 %) and DZ (49.1 %) individuals
from a total of 1184 unique families. The age at collec-
tion date of blood for DNA extraction was in the range
of 19–82.2 years (mean age, 55.99 years; median age,
56.60 years; std. dev. 10.32 years).
MeDIP-seq
DNA sample preparation, MeDIP reaction and Illumina
second-generation sequencing were all performed at
BGI-Shenzhen, Shenzhen, China. Fragmentation of the
whole peripheral blood TwinsUK DNA was via sonic-
ation with a Covaris system (Woburn, MA, USA).
Libraries for sequencing were prepared from 5 ug of
fragmented genomic DNA. End repair, <A > base
addition and adaptor ligation steps were performed
using Illumina’s DNA Sample Prep kit for single-end se-
quencing. The anti-5mC antibody (Diagenode) was used
to immunoprecipitate the adaptor-ligated DNA and the
resultant MeDIP was validated by quantitative polymer-
ase chain reaction (PCR). This captured DNA was then
purified with Zymo DNA Clean & Concentrator™-5
(Zymo Research) and subsequently amplified with
adaptor-mediated PCR. Fragments of size 200–500 bp
were selected by gel excision and then QC assessed by
Agilent BioAnalyzer analysis. These libraries were then
sequenced on the Illumina platform. Sequencing data
passed initial QC for base composition assessed via
FASTQC (v0.10.0) (http://www.bioinformatics.bbsrc.a-
c.uk/projects/fastqc). MeDIP-seq data were processed
with BWA (Burrows-Wheeler Aligner) alignment [77]
(passing a mapping quality score of Q10), with
duplicates removal, FastQC and SAMTools [78] QC and
MEDIPS(v1.0) [79] for MeDIP-specific analysis, QC,
reads per million (RPM) and absolute methylation score
(AMS) generation. The average high quality BWA
aligned reads was ~16.9 million per sample for the dis-
covery set of 2238 and ~16.8 million for the replication
set of 2084. Further QC was performed via R (correl-
ation matrix, hierarchical clustering, dendogram, heat-
map, density plot) and batch effects inspection by
principle component analysis. Processed data for statis-
tical analysis are BED files of genomic windows (500-bp,
250-bp slide) with RPM scores. All human genome coor-
dinates, calculations performed and those cited are in
build hg19/GRCh37.
GWAS LD blocks
The analysis was performed on the a priori functionally
enriched genomic regions contained within the LD
blocks of the NIH GWAS SNP catalogue [24, 25]. The
LD blocks were ascertained from the GRCh37 genetic
map, downloaded from Center of Statistic Genetics,
University of Michigan, Locuszoom 1.3 [80], with
recombination rate of 10 cM/Mb boundaries. LD blocks
were further pruned to those ≤ 10 Mb in size. We selected
the 8093 curated GWAS SNPs with p value < 1 × 10–7
deposited within the NIH GWAS catalogue as at
December 2014. Due to co-associations for the same SNP,
these are 5522 unique individual SNPs and 5477 of these
resided within the above-identified LD blocks. In fact,
these represented 2709 distinct LD blocks once account-
ing for SNPs present within the same block. These regions
cover ~22.1 % of the human genome.
Age-associated DNA methylation analysis
All statistical analyses were run in the R (3.0.0) environ-
ment [81]. The lme4 package [82] was employed to
perform a linear mixed effect analysis of the relationship
between chronological age at DNA extraction and DNA
methylation, which was represented as normalised RPM
values within the 500-bp windows. Additional fixed
effects terms included allelic count of the haplotype-
tagging SNP, smoking status, batch, blood cell subtypes
(lymphocytes, monocyte, neutrophil and eosinophil)
with family and zygosity as random effects. This model
for DNA methylation age analysis is similar to that used
previously in array based analyses [15] with the add-
itional inclusion of genetic allelic information. p values
were calculated with the ANOVA function by likelihood
ratio test of the full model including age versus null
model excluding this variable. A Bonferroni multiple test-
ing correction was calculated by the total number of DNA
methylation windows included in the analysis (2,708,462),
giving a p value significance level of <1.85 × 10–8 (see
“Study Design” in Additional file 6: Figure S4).
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The immunoprecipitation reaction in MeDIP-seq data
is extremely susceptible to the influence of genetic vari-
ation in CpG number (due to CpG-SNPs, CNVs, indels
and STRs), leading to a direct relationship between the
number of methylated cytosines in the DNA fragment
and the amount of DNA captured by the antibody as
discussed by Okitsu and Hsieh [22]. We accounted for
this influence by the inclusion of the haplotype-tagging
common SNP data for each LD block examined within
our statistical model. We further also removed the
ENCODE poor mappability blacklist regions [28] from
any further analysis (13,726 500-bp windows). Shared
trans factors, however, cannot be accounted for, al-
though are much less frequent [83], but the large repli-
cation set, described below, adds powerful support to
the discovery findings.
An interaction between genotype and age was directly
tested for by comparing the full model, but with DNA
methylation and age included as interacting factors, and
the full model in the initial analysis, with again a likeli-
hood ratio test via ANOVA to derive significance levels.
As the direct confounding of common genetic effects
was included in the initial a-DMR analysis with strict
Bonferroni cutoff, we then overlapped these results with
our a-DMR set to identify those robust a-DMRs with
potential evidence of interaction.
Novelty of a-DMRs analysis
We identified 14 previous studies [3–16] that had been
performed for DNA methylation changes in blood with
respect to age with available data for comparison and
downloaded these results placing CG positions at their
correct co-ordinates from Illumina array annotation files
and converting all that were in previous builds to hg19/
GRCh37 via UCSC tools liftOver [84]. These were
merged and compared via BEDtools (v.2.17.0) and are
available in Additional file 7.
Blood-cell discordant monozygotic twin EWAS
A MZ discordant EWAS in 54 MZ pairs that possessed
precise white blood cell data within this DNA methy-
lome dataset was performed. These data were generated
by Roederer et al. [44] and included calculations for
CD4+ helper T, CD8+ cytotoxic T, T cell, natural killer
cell, CD34+ multipotential haematopoietic stem cell and
B cells. MZ twin pairs’ discordance for each blood-cell
trait was calculated. The 500-bp DNA methylome win-
dows for analysis required ≥90 % of individuals with
non-zero values. Residuals from the linear regression
model of RPM methylation scores with adjustments for
smoking, leukocyte counts, age at DNA extraction and
batch were normalised (qqnorm) and then the high–low
difference significance was compared by one-sided
T-test.
Enrichment analysis
Initial exploration of a-DMRs was performed via
Epiexplorer [85]. This enabled enrichment for chromatin
state (ChromHMM), histone modifications and add-
itional ENCODE and Roadmap data to be investigated
first. Comparisons were made with ChromHMM in nine
tissues from Encode Broad HMM (Gm12878; H1hesc;
Hepg2; Hmec; Hsmm; Huvec; K562; Nhek; Nhlf ) and
then with combined segmentation in six tissues - Encode
AwgSegmentation (Gm12878; H1hesc; Helas3; Hepg2;
Huvec; K562) via UCSC. Overlap in genetic and func-
tional data was calculated with BEDtools (v.2.17.0)
command intersectBed, compared with non-overlapping
LD block 500-bp windows with –f 0.1 parameter (mod-
erate overlap). The genetic regions compared for enrich-
ment were CpG islands, TFBSs from ENCODE v3 (690
datasets from wgEncodeRegTfbsClusteredV3 [86]), DHS
in 125 cell types from ENCODE analysis [55] and Verte-
brate Multiz Alignment and Conservation (100 Species)
from 100Vert_El_phastConsElement100way bedfile
(~10.1 m regions), all downloaded from UCSC [87].
FANTOM5 enhancers regions were from Anderson et
al. [36] and ‘Dynamic’ regions from Ziller et al. [66].
A further a-DMR enrichment analysis was performed
with the Genomic Regions Enrichment of Annotations
Tool (GREAT v3.0.0) [88] region-based binomial analysis
with basal, but the extension parameters reduced from
the default (constitutive 5.0 kb upstream, 1.0 kb down-
stream and up to 100 kb max extension, not 1 Mb). Cu-
rated regulatory domains were included and all LD
block regions were used as the background set.
For TFBS motif enrichment, we used the TRAP
method [37] and the MEME suit (MEME-ChIP [38] and
TOMTOM (v4.10.2) [89]). FASTA sequence files of the
71 a-DMRs were inputted as separated hypomethylated
and hypermethylated groups. In TRAP they were com-
pared to the JASPAR vertebrates with a background
model of human promoters. MEME-Chip compared
with a set of 1229 DNA motifs, in the range of 7–23 in
length (average length 13.8), from the database Human
and Mouse (in silico).
Validation analysis
Within the a-DMRs, 116 CpG probes from the Infinium
Human Methylation450 BeadChip reside that passed QC,
as detailed below. These were blood-derived CpG methy-
lation scores from 811 female individuals, 89.1 % over-
lapped with the MeDIP samples. QC included removal of
probes that failed detection in at least one sample and
with a bead count less than 3 in more than 5 % of the
samples, and probes for which the 50 bp sequence aligned
to multiple locations in the genome. Cell type proportions
were estimated for CD8+ T cells, CD4+ T cells, B cells,
natural killer cells, granulocytes and monocytes [43]. All
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data were normalised using the intra-array normalisa-
tion, beta-mixture quantile dilation (BMIQ) [90] to cor-
rect for probe type bias. The validation was performed
using a linear mixed effects model fitted on standardised
beta values per probe (N(0,1)) with age, genotype as al-
lelic count, smoking status, beadchip, position on the
beadchip, granulocytes, monocytes and CD8+ T cells as
fixed effects, as well as family and zygosity as random
effects. To assess for significance, ANOVA was used to
compare this model to a null model without age.
Replication analysis
We utilised an additional 2084 peripheral blood MeDIP-
seq data, also available from TwinsUK, for our replica-
tion set. None of these individuals were present in the
discovery set and do not differ from that set in any
selective way. These samples were in the age range of
16–82.2 years (mean age, 51.00 years; median age,
53.40 years; std. dev. 14.91), were 87.04 % female and in-
cluded 1897 samples from 1710 MZ individuals (582
pairs, 546 lone) and 187 samples from 159 DZ individ-
uals (46 pairs, 67 lone), with 215 possessing data from
>1 time point. Analysis was performed as for the discov-
ery set using an identical linear mixed effect model, for
normalised DNA methylation (500 bp windows) with
age at DNA collection; however, these samples did not
possess genotype, smoking or leukocyte information,
and therefore only included the additional fixed effect of
batch and random effects of zygosity and family.
Tissue-specific investigation
The DHS from 125 cell type experiments from
ENCODE analysis [55] were used for tissue-specific ana-
lysis of the a-DMRs. This dataset includes 22 blood tis-
sue related samples. Broad disease classes were taken
from Maurano et al. [60].
Additional files
Additional file 1: BED file of a-DMRs with UCSC browser header.
(BED 1 kb)
Additional file 2: Supplementary Tables S1–7. (XLSX 1125 kb)
Additional file 3: Figure S1. Selected a-DMRs within (i) Genomic Loca-
tion; From Top: a-DMRs (purple), Gene, DNase I HS Clusters, Transcription
Factor ChIPseq, ChromHMM Segmentation, Combined Segmentation, &
Conservation. (ii) Scatterplot: X axis = Age, Y axis = Normalised Methyla-
tion. C) CDC14B, D) HFE, E) NR4A2, F) GHSR, G) ZNF300P1, H) ZNF577, I)
TAOK2, J) AFF1 locus. (PDF 5.8 mb)
Additional file 4: Figure S2. All a-DMRs within (1) genomic location.
Top: a-DMRs (purple), gene, DHS clusters, transcription factor ChIP-seq,
ChromHMM segmentation, combined segmentation and conservation;
and (2) scatterplot: x-axis = Age, y-axis = Normalised methylation.
(PDF 34909 kb)
Additional file 5: Figure S3. Genotype-interaction analysis. Variation in
ageing signal depending on genotype. Homozygote SNP trait related
allele is in red. Left: Scatterplot: x-axis = Age, y-axis = Normalised
methylation. Right: Boxplot: three genotype categories separated into two
groups by ≤ or > median age (56.6 years). (PDF 910 kb)
Additional file 6: Figure S4. Study design flowchart. (PDF 152 kb)
Additional file 7: BED file of combined 14 ageing studies.
(BED 2508 kb)
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